Caitlin John’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.26K Sell
34
-18
-35% -$1.84K ﹤0.01% 730
2026
Q1
$5.68K Sell
52
-46
-47% -$4.38K ﹤0.01% 602
2025
Q4
$7.95K Sell
98
-15,886
-99% -$1.37M 0.01% 572
2025
Q3
$1.4M Buy
15,984
+366
+2% +$32.7K 0.97% 32
2025
Q2
$1.3M Buy
+15,618
New +$1.31M 1.18% 29
2024
Q1
Sell
-1
Closed -$62 918
2023
Q4
$57 Buy
+1
New +$52 ﹤0.01% 878

Other funds holding LMAT

Caitlin John's LMAT Position: Q2 2026 in Review

Caitlin John reduced its LeMaitre Vascular (LMAT) stake by 35% in Q2 2026, selling an estimated $1.84K and leaving 34 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Caitlin John first reported a position in LMAT in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.4M in Q3 2025. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Caitlin John held 34 shares of LeMaitre Vascular worth $3.26K as of Q2 2026.
  • Caitlin John sold 18 LeMaitre Vascular shares in Q2 2026, an estimated $1.84K.
  • LeMaitre Vascular made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #730 holding.
  • Caitlin John first reported a position in LeMaitre Vascular in Q4 2023 and has held it in 6 quarters since.
  • Caitlin John's LeMaitre Vascular position peaked at $1.4M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.